Biogen Inc. (NASDAQ:BIIB) Receives $195.85 Average Target Price from Analysts
Shares of Biogen Inc. (NASDAQ:BIIB – Get Free Report) have received an average rating of “Hold” from the thirty-two brokerages that are covering the company, Marketbeat reports. Twenty analysts have rated the stock with a hold recommendation and twelve have issued a buy recommendation on the company. The average 1 year price objective among analysts […]
Shares of Biogen Inc. (NASDAQ:BIIB – Get Free Report) have received an average rating of “Hold” from the thirty-two brokerages that are covering the company, Marketbeat reports. Twenty analysts have rated the stock with a hold recommendation and twelve have issued a buy recommendation on the company. The average 1 year price objective among analysts […]
